SecBot SecBot
8-K ·Filed Apr 27, 2026

GH

Guardant Health, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001193125-26-182391
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for announcement of a successor CMO and any associated changes to clinical strategy. The departure is not unexpected enough to warrant immediate trading action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$83.10
T+0 close · Apr 27, 2026 · via day close
Latest settled
+80.74%
T+60 · $150.20
Vs SPY
+77.02%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 28 $83.10entry
  2. T+1 · 7mo ago −3.03%α −3.02% · $80.59
  3. T+5 · 7mo ago +9.71%α +8.01% · $91.17
  4. T+20 · 6mo ago +44.22%α +38.75% · $119.85
  5. T+60 · 4mo ago +80.74%α +77.02% · $150.20
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Guardant Health announced the resignation of Chief Medical Officer Dr. Craig Eagle, effective May 8, 2026. No replacement has been named, and no reason for the departure was provided. This is a routine C-suite departure without additional context, making it a low-impact event.

Key Facts

  • Chief Medical Officer Craig Eagle, M.D. resigned effective May 8, 2026.
  • No replacement named in the filing.
  • No reason for resignation provided (no 'retired' or 'terminated' language).
  • Filing date: April 27, 2026.

Financial Impact

No financial impact disclosed.

Risk Factors

  • Potential disruption to clinical development programs if a replacement is not named promptly.
  • No reason given for resignation could indicate internal discord, though not confirmed.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
88% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-182391
Document: 0001193125-26-182391-index-headers.html0001193125-26-182391
Document: 0001193125-26-182391-index.html0001193125-26-182391
Document: 0001193125-26-182391.txt0001193125-26-182391

Track record

38 reports on GH

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
  2. Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
  3. Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
  5. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
  6. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
  7. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
  8. Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
  9. Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
  10. Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens in 7h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026